^
Association details:
Biomarker:No biomarker
Cancer:Chronic Myeloid Leukemia
Drug:busulfan (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
Published date:
12/24/2003
Excerpt:
MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia.